Internal Medicine · Sylmar, CA
NPI
1063541654
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
14445 Olive View Drive, North Annex
Sylmar, CA, 91342
Phone (818) 364-3632
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,272
26 services
Medicare patients, 2024
11
Average age 74
Drug cost, 2024
$320K
1,117 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug John Cho prescribed most often to Medicare patients was Breyna (Budesonide/Formoterol Fumarate), with 216 prescriptions and refills. In total John Cho wrote 1,117 Medicare prescriptions that cost $320K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Breyna Budesonide/Formoterol Fumarate | 216 | 465 | 78 | $57K |
| Spiriva Respimat Tiotropium Bromide | 169 | 469 | 63 | $137K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 144 | 159 | 82 | $2,619 |
| Montelukast Sodium Generic | 137 | 364 | 41 | $1,414 |
| Prednisone Generic | 70 | 87 | 36 | $590 |
| Alvesco Ciclesonide | 47 | 81 | 22 | $7,258 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 37 | 91 | 15 | $9,146 |
| Azelastine Hcl Generic | 35 | 41 | 14 | $686 |
| Doxycycline Monohydrate Generic | 34 | 34 | 30 | $332 |
| Cefpodoxime Proxetil Generic | 29 | 29 | 28 | $927 |
| Symbicort Budesonide/Formoterol Fumarate | 26 | 53 | Under 11 | $18K |
| Dulera Mometasone/Formoterol | 21 | 40 | Under 11 | $19K |
| Ipratropium Bromide Generic | 21 | 28 | 12 | $445 |
| Azithromycin Generic | 19 | 19 | 13 | $122 |
| Fluticasone Propionate Generic | 14 | 21 | Under 11 | $262 |
Brand drugs: 459 claims; generic drugs: 658 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to John Cho were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.